Hippo (NYSE:HIPO) Shares Down 4.9% – Here’s What Happened

Hippo Holdings Inc. (NYSE:HIPOGet Free Report)’s stock price was down 4.9% during trading on Thursday . The company traded as low as $25.26 and last traded at $25.46. Approximately 82,196 shares were traded during trading, a decline of 49% from the average daily volume of 162,303 shares. The stock had previously closed at $26.77.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. JMP Securities boosted their price target on Hippo from $25.00 to $35.00 and gave the stock a “market outperform” rating in a report on Friday, November 22nd. Jefferies Financial Group reduced their target price on shares of Hippo from $29.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, October 9th.

Get Our Latest Report on HIPO

Hippo Trading Up 4.5 %

The stock’s 50 day moving average price is $27.44 and its 200 day moving average price is $21.15. The company has a market cap of $652.85 million, a price-to-earnings ratio of -5.14 and a beta of 1.47.

Insider Buying and Selling at Hippo

In related news, CAO Anirudh Badia sold 2,552 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $24.49, for a total value of $62,498.48. Following the completion of the sale, the chief accounting officer now directly owns 102,315 shares in the company, valued at approximately $2,505,694.35. This represents a 2.43 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Richard Mccathron sold 15,000 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $30.16, for a total value of $452,400.00. Following the transaction, the chief executive officer now owns 339,623 shares in the company, valued at approximately $10,243,029.68. This represents a 4.23 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 67,771 shares of company stock worth $1,818,963 in the last quarter. 11.37% of the stock is owned by insiders.

Institutional Trading of Hippo

Several large investors have recently bought and sold shares of the company. JPMorgan Chase & Co. increased its stake in shares of Hippo by 205.0% in the third quarter. JPMorgan Chase & Co. now owns 146,176 shares of the company’s stock worth $2,467,000 after buying an additional 98,256 shares during the last quarter. Jacobs Levy Equity Management Inc. bought a new stake in shares of Hippo in the 3rd quarter worth about $864,000. Dimensional Fund Advisors LP bought a new stake in shares of Hippo in the 2nd quarter worth about $629,000. State Street Corp lifted its position in shares of Hippo by 10.5% during the third quarter. State Street Corp now owns 377,537 shares of the company’s stock worth $6,373,000 after purchasing an additional 35,743 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of Hippo by 99.2% during the second quarter. Bank of New York Mellon Corp now owns 61,089 shares of the company’s stock worth $1,050,000 after purchasing an additional 30,418 shares during the last quarter. Institutional investors and hedge funds own 43.01% of the company’s stock.

About Hippo

(Get Free Report)

Hippo Holdings Inc provides property and casualty insurance products to individuals and business customers primarily in the United States. The company operates through three segments: Services, Insurance-as-a-Service, and Hippo Home Insurance Program. Its insurance products include homeowners' insurance against risks of fire, wind, and theft, as well as other personal lines policies from third party carriers; and personal and commercial, as well as home, auto, cyber, small business, life, specialty lines, and other insurance products.

Featured Stories

Receive News & Ratings for Hippo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hippo and related companies with MarketBeat.com's FREE daily email newsletter.